Price Band
₹65 - ₹70
Lot Size
2000
Issue Size
₹13.02 Cr
GMP
N/A
Subscription
22.27x
Analyzing...
IPO Schedule
1
Open
23 Sept 2025
2
Close
25 Sept 2025
3
Allotment
26 Sept 2025
4
Listing
30 Sept 2025
About Aptus Pharma Ltd
Aptus Pharma Ltd is an SME focused on [insert specific area of pharma, e.g., manufacturing and marketing of generic pharmaceutical products]. The company aims to leverage its established network and product portfolio to expand its market presence and profitability.
Key Strengths
- High Return on Equity (ROE) of 44.50% indicates efficient utilization of shareholder equity.
- Relatively low Price-to-Earnings (P/E) ratio of 11.29 suggests the IPO may be attractively priced compared to industry peers (requires further peer comparison).
- [Insert a strength specific to Aptus Pharma's business model, e.g., Strong distribution network in key regions]
- [Insert a strength specific to Aptus Pharma's product portfolio, e.g., Diversified product portfolio mitigating risk]
- [Insert a strength regarding Aptus Pharma's management, e.g., Experienced management team with a proven track record]
Risk Factors
- •SME IPOs are inherently riskier due to lower liquidity and higher volatility.
- •The pharmaceutical industry is highly regulated, and changes in regulations can significantly impact profitability.
- •Competition from larger and more established pharmaceutical companies poses a significant threat.
Valuation Analysis
The IPO appears reasonably valued based on the P/E ratio, but a thorough analysis of the company's financials, growth prospects, and peer comparisons is crucial before making an investment decision.
IPO Details
ExchangeNSE
SegmentSME
ISININE15XJ01010
NSE SymbolAPPL
Face Value₹10
Lot Size2000
Issue Size₹13.02 Cr
Key Metrics
ROE44.50%
ROCE45.66%
P/E Ratio11.29
Industry P/E25
EPS6.20
Debt/Equity1.49
Subscription
Total1.92x
Documents
Key Dates
Open Date23 Sept 2025
Close Date25 Sept 2025
Allotment26 Sept 2025
Listing30 Sept 2025